Journal ArticleAlzheimers Res Ther · January 7, 2023
BACKGROUND: High continuity of care (COC) is associated with better clinical outcomes among older adults. The impact of amyloid-β PET scan on COC among adults with mild cognitive impairment (MCI) or dementia of uncertain etiology is unknown. METHODS: We li ...
Full textLink to itemCite
Journal ArticleNEJM Catalyst Innovations in Care Delivery · April 20, 2022
Despite a growing body of evidence documenting the problem of low-value care, our understanding of how to effectively reduce or eliminate it remains limited. Through semistructured interviews with U.S. health care organizations with demonstrated experience ...
Full textCite
Journal ArticleJ Alzheimers Dis · 2022
BACKGROUND: Diagnostic tests, such as amyloid-β positron emission tomography (PET) scans, can increase appropriate therapeutic management for the underlying causes of cognitive decline. To evaluate the full utility of this diagnostic tool, information is n ...
Full textLink to itemCite
Journal ArticleFuture Oncol · October 2021
Over the past decade, the financial burden of cancer care on patients and their families has garnered increased attention. Many of the potential solutions have focused on system-level interventions such as adopting value-based payment models and negotiatin ...
Full textLink to itemCite
Journal ArticleAm J Manag Care · February 2019
OBJECTIVES: To better understand the prevalence of US value-based payment arrangements (VBAs), their characteristics, and the factors that facilitate their success or act as barriers to their implementation. STUDY DESIGN: Surveys were administered to a con ...
Link to itemCite
Journal ArticleValue Health · February 2017
Rising costs without perceived proportional improvements in quality and outcomes have motivated fundamental shifts in health care delivery and payment to achieve better value. Aligned with these efforts, several value assessment frameworks have been introd ...
Full textLink to itemCite
Chapter · April 19, 2016
Focusing on how to save money, not by restricting access to necessary services, but by using available resources more efficiently and rationally, this volume arms decision makers with the tools they need to make wise choices in an area ... ...
Cite
Journal ArticleHealth Economics, Policy and Law · April 2015
AbstractThis study examined the role of prospective payment systems in the adoption of new medical technologies across different countries. A literature review was conducted to provide background for the study and guide dev ...
Full textCite
Journal ArticleThe Milbank Quarterly · March 2014
ContextRecent debates and events have brought into question the effectiveness of existing regulatory frameworks for medical devices in the United States and Europe to ensure their performance, safety, and quality. ...
Full textCite
Journal ArticleJournal of Clinical Oncology · December 1, 2012
Purpose To assess the relevance of the experience of the National Institute for Health and Clinical Excellence (NICE) in the United Kingdom to the comparative effectiveness research (CER) initiative in the United ...
Full textCite
Journal ArticleHealth Economics, Policy and Law · October 2012
AbstractNew cancer therapies offer the hope of improved diagnosis to patients with life-threatening disease. Over the past 5–10 years, a number of specialty drugs have entered clinical practice to provide better systemic th ...
Full textCite
Chapter · April 12, 2012
This timely volume examines the economics of the biopharmaceutical industry, with eighteen chapters by leading academic health economists. ...
Cite
Journal ArticleHealth Economics, Policy and Law · January 5, 2012
AbstractHealth technology assessment (HTA) has assumed an increasing role in health systems in recent years, with many countries establishing agencies or programmes to evaluate health technology and other interventions to i ...
Full textCite
Journal ArticleJournal of Health Politics, Policy and Law · February 1, 2011
Infectious diseases are a long-standing and continuing threat to health and welfare, with their containment dependent on national disease surveillance and response capacities. This article discusses infectious disease surveillance in the United Sta ...
Full textCite
Book · 2008
This report addresses the concepts and controversy surrounding health technology assessment in Europe, with a particular focus on selected Member States including Sweden, the Netherlands, Finland, France, Germany and the United Kingdom. ...
Cite
